AAS
Avantax Advisory Services’s Iovance Biotherapeutics IOVA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $28K | Sell |
16,299
-2,261
| -12% | -$3.89K | ﹤0.01% | 2335 |
|
2025
Q1 | $61.8K | Buy |
18,560
+5,205
| +39% | +$17.3K | ﹤0.01% | 2190 |
|
2024
Q4 | $98.8K | Sell |
13,355
-1,804
| -12% | -$13.4K | ﹤0.01% | 2124 |
|
2024
Q3 | $142K | Buy |
15,159
+3,750
| +33% | +$35.2K | ﹤0.01% | 2043 |
|
2024
Q2 | $91.5K | Buy |
+11,409
| New | +$91.5K | ﹤0.01% | 2016 |
|